Viral Infection Clinical Trials

12 recruiting

Viral Infection Trials at a Glance

25 actively recruiting trials for viral infection are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Phase 1 with 7 trials, with the heaviest enrollment activity in Houston, Cincinnati, and Columbus. Lead sponsors running viral infection studies include Children's Hospital Medical Center, Cincinnati, Assistance Publique - Hôpitaux de Paris, and Arkansas Children's Hospital Research Institute.

Browse viral infection trials by phase

Treatments under study

About Viral Infection Clinical Trials

Looking for clinical trials for Viral Infection? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Viral Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Viral Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 25 trials

Recruiting
Phase 1

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed+4 more
M.D. Anderson Cancer Center30 enrolled1 locationNCT05101213
Recruiting
Phase 1Phase 2

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Viral InfectionPrimary Immune Deficiency Disorder
New York Medical College40 enrolled7 locationsNCT04197596
Recruiting
Phase 3

Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years

Acute Respiratory Viral Infection
Materia Medica Holding374 enrolled35 locationsNCT06715891
Recruiting
Phase 2

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant

Allogeneic Stell Cell TransplantViral Infection
Children's Hospital Medical Center, Cincinnati180 enrolled1 locationNCT04230356
Recruiting
Not Applicable

Dime La VerDAD: Verify, Debunk, and Disseminate

COVID-19Health BehaviorInfluenza+2 more
University of Chicago1,400 enrolled4 locationsNCT06417762
Recruiting
Phase 2

Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.

InfluenzaAcute Respiratory Viral Infection
Valenta Pharm JSC300 enrolled11 locationsNCT07420985
Recruiting
Phase 1

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute48 enrolled3 locationsNCT04691622
Recruiting
Phase 3

Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

Respiratory Viral Infection
Joincare Pharmaceutical Group Industry Co., Ltd177 enrolled1 locationNCT07357051
Recruiting
Not Applicable

Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract

Viral InfectionMicrobial ColonizationOral Bacterial Infection+1 more
University of California, Irvine200 enrolled1 locationNCT05603650
Recruiting
Phase 2

Third Party Viral Specific T-cells (VSTs)

Viral Infection
Children's Hospital Medical Center, Cincinnati750 enrolled4 locationsNCT02532452
Recruiting
Not Applicable

School Inner City Air Study

Viral Infection
Massachusetts General Hospital200 enrolled1 locationNCT05953233
Recruiting
Phase 3

Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza

Respiratory Viral Infection
Nanjing Zenshine Pharmaceuticals168 enrolled2 locationsNCT07095257
Recruiting
Phase 1Phase 2

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Cytomegaloviral InfectionHematopoietic Cell Transplant Recipient
City of Hope Medical Center80 enrolled1 locationNCT03354728
Recruiting

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Solid Organ TransplantHematopoietic Cell TransplantRespiratory Viral Infection
Arkansas Children's Hospital Research Institute2,000 enrolled27 locationsNCT05550298
Recruiting
Phase 1

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Viral Infection
Baylor College of Medicine47 enrolled2 locationsNCT04013802
Recruiting

Combination of Leukocyte Cell Surface Biomarkers Measured by Cytometry, to Differentiate Bacterial From Viral Infections in Emergency Department: a Multicentric Cohort for the Validation of Diagnostic Performances

Bacterial and Viral Infections
Assistance Publique - Hôpitaux de Paris500 enrolled3 locationsNCT06155266
Recruiting

REVIVe: Frailty, Rehabilitation, and Outcomes in Critically Ill Adult and Pediatric Survivors of COVID-19 or ARI

COVID-19Viral InfectionRespiratory Disease
McMaster University900 enrolled28 locationsNCT05246098
Recruiting
Not Applicable

Reducing Urban Cervical Cancer Disparities

Cervical CancerPapilloma Viral Infection
Fox Chase Cancer Center546 enrolled3 locationsNCT06416150
Recruiting
Phase 1Phase 2

Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis

Viral Infection
Catherine Bollard36 enrolled2 locationsNCT03594981
Recruiting

Psycho-emotional Impact of Preoperative Counselling in Cervico-carcinoma Screening Programs

HPV InfectionPhysiological StressPapilloma Viral Infection
University of Turin, Italy300 enrolled1 locationNCT06500767